Stay updated on Alvelestat in alpha1-antitrypsin COPD: Clinical Trial
Sign up to get notified when there's something new on the Alvelestat in alpha1-antitrypsin COPD: Clinical Trial page.

Latest updates to the Alvelestat in alpha1-antitrypsin COPD: Clinical Trial page
- Check5 days agoChange DetectedOnly the site’s revision label was updated from v3.4.1 to v3.4.2; there are no visible changes to the page content or features. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check12 days agoChange DetectedRevision numbers on the page were updated: added v3.4.1 and removed v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check13 days agoChange DetectedThe site updated from version v3.4.0 to v3.4.1; no visible changes to study details or layout are evident.SummaryDifference0.0%

- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedPage footer revision updated from v3.3.3 to v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check56 days agoChange DetectedAdded a centralized Locations section listing study sites across the United States and Canada (Alabama, California, North Carolina, Alberta, British Columbia, Ontario, Saskatchewan) and removed the older per-location pages (e.g., Alabama Locations) and the HHS Vulnerability Disclosure link.SummaryDifference0.7%

- Check85 days agoChange DetectedThe study page shows a revision change from v3.2.0 to v3.3.2. This is a metadata or system update and does not modify study details or eligibility.SummaryDifference0.0%

Stay in the know with updates to Alvelestat in alpha1-antitrypsin COPD: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Alvelestat in alpha1-antitrypsin COPD: Clinical Trial page.